Latest / Health News Today | 2 Min News | The Daily News Now!
Medicare’s $50 Weight Loss Drug Pilot
Starting July 2026, Medicare’s new GLP-1 Bridge program will offer weight loss meds like Wegovy and Zepbound for just $50 a month—changing lives for millions with obesity. But this isn’t permanent: it’s an 18-month test run with strict eligibility, including BMI thresholds or coexisting conditions. Crucially, the $50 doesn’t count toward your Part D spending limit, so even maxed-out patients pay it. Experts warn that without long-term coverage, patients risk regaining weight—and the future of access remains uncertain. Support the show:Get a discount at https://solipillow.com/discount/dnn…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.